Walgreens (NYSE: WAG) (Nasdaq: WAG) had September sales of $5.92 billion, an increase of 8.0 percent from $5.48 billion for the same month in fiscal 2013.
Total front-end sales increased 4.1 percent compared with the same month in fiscal 2013, while comparable store front-end sales increased 2.9 percent. Customer traffic in comparable stores decreased 0.8 percent while basket size increased 3.7 percent.
Prescriptions filled at comparable stores increased by 9.6 percent in September and increased 6.7 percent on a calendar day-shift adjusted basis. This year’s September had one additional Monday and one fewer Saturday compared with September 2012. These calendar shifts positively impacted prescriptions filled at comparable stores by 2.9 percentage points.
Prescriptions filled at comparable stores also were positively impacted by 0.8 percentage point due to more flu shots versus last year and were negatively impacted by 0.2 percentage point due to lower incidence of flu in this year’s September.September pharmacy sales increased by 10.4 percent, while comparable store pharmacy sales increased 10.2 percent and increased by a calendar day-shift adjusted 7.3 percent. Calendar day shifts positively impacted pharmacy sales in comparable stores by 2.9 percentage points. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 0.7 percentage point due to generic drug introductions in the last 12 months, and were positively impacted by 0.5 percentage point due to more flu shots versus last year. Pharmacy sales accounted for 65.0 percent of total sales for the month. Flu shots administered at pharmacies and clinics season to date were more than 1.9 million versus approximately 1.6 million last year. Sales in comparable stores increased by 7.4 percent in September. Calendar day shifts positively impacted total comparable sales by 1.9 percentage points, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 0.5 percentage point.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts